Back to Search
DEVIKA SACHDEV, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1568087419Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (16)
Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells.
PMID 18418709·Breast Cancer Res Treat·2009
7-preclinical
Comparison of an in-house PCR assay, direct fluorescence assay and the Roche AMPLICOR Chlamydia trachomatis kit for detection of C. trachomatis.
PMID 19502371·J Med Microbiol·2009
4-observational
Sequencing of type I insulin-like growth factor receptor inhibition affects chemotherapy response in vitro and in vivo.
PMID 19351773·Clin Cancer Res·2009
7-preclinical
The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes.
PMID 19349871·J Acquir Immune Defic Syndr·2009
8-other
A national physician survey on prescribing syringes as an HIV prevention measure.
PMID 19505336·Subst Abuse Treat Prev Policy·2009
8-other
Regulation of breast cancer metastasis by IGF signaling.
PMID 19030970·J Mammary Gland Biol Neoplasia·2008
6-review
Drug evaluation: CP-751871, a human antibody against type I insulin-like growth factor receptor for the potential treatment of cancer.
PMID 17608029·Curr Opin Mol Ther·2007
8-other
Disrupting insulin-like growth factor signaling as a potential cancer therapy.
PMID 17237261·Mol Cancer Ther·2007
6-review
Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer.
PMID 16947084·J Mammary Gland Biol Neoplasia·2006
6-review
Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin-like growth factor therapy in breast cancer.
PMID 16489046·Cancer Res·2006
7-preclinical
Motility response to insulin-like growth factor-I (IGF-I) in MCF-7 cells is associated with IRS-2 activation and integrin expression.
PMID 14997047·Breast Cancer Res Treat·2004
8-other
A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells.
PMID 14615489·J Biol Chem·2004
7-preclinical
A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
PMID 12566306·Cancer Res·2003
7-preclinical
New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation.
PMID 12538509·Clin Cancer Res·2003
6-review
Fusions to maltose-binding protein: control of folding and solubility in protein purification.
PMID 11036650·Methods Enzymol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 125 PATERSON ST
NEW BRUNSWICK, NJ 08901 - Phone
- (732) 235-7628
Quick Facts
- NPI
- 1568087419
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile